丙型肝炎病毒的临床试验
总计24924个结果
-
Bristol-Myers Squibb完全的
-
Bristol-Myers SquibbPharmasset完全的
-
Biocad完全的
-
Janssen R&D IrelandGilead Sciences完全的
-
Merck Sharp & Dohme LLC完全的
-
Centre hospitalier de l'Université de Montréal...Hoffmann-La Roche; Centre de Recherche du Centre Hospitalier de l'Université de Montréal完全的
-
Third Affiliated Hospital, Sun Yat-Sen University未知
-
The Catholic University of KoreaUlsan University Hospital; Yonsei University; Kyungpook National University Hospital; Inje University 和其他合作者完全的
-
Peregrine Pharmaceuticals完全的
-
Gilead Sciences终止丙肝病毒感染美国, 英国, 德国, 加拿大, 波多黎各, 波兰
-
Merck Sharp & Dohme LLC撤销
-
Seoul National University Boramae HospitalRoche Pharma AG完全的
-
Bausch Health Americas, Inc.完全的
-
ANRS, Emerging Infectious DiseasesInstitut Pasteur未知
-
Dynavax Technologies CorporationPPD; Synteract, Inc.完全的
-
Merck Sharp & Dohme LLC完全的
-
Alios Biopharma Inc.Vertex Pharmaceuticals Incorporated完全的
-
Kaohsiung Medical University Chung-Ho Memorial...完全的
-
Bristol-Myers Squibb不再可用
-
Janssen R&D Ireland完全的
-
National Opinion Research CenterUniversity of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai; Centers for Disease... 和其他合作者完全的
-
Foundation for Liver ResearchHoffmann-La Roche终止
-
National Taiwan University HospitalNational Science Council, Taiwan; Department of Health, Executive Yuan, R.O.C. (Taiwan)完全的
-
Mitsubishi Tanabe Pharma CorporationVertex Pharmaceuticals Incorporated完全的